metricas
covid
Buscar en
Revista Española de Anestesiología y Reanimación (English Edition)
Toda la web
Inicio Revista Española de Anestesiología y Reanimación (English Edition) COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult
Journal Information
Vol. 69. Issue 1.
Pages 43-47 (January 2022)
Share
Share
Download PDF
More article options
Visits
271
Vol. 69. Issue 1.
Pages 43-47 (January 2022)
Case report
COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult
Síndrome inflamatorio multisistémico de tipo Kawasaki asociado a COVID-19 en un adulto
Visits
271
Y. Elouardi
Corresponding author
y.elouardi.rea@gmail.com

Corresponding author.
, H. Rebahi, Y. Zarrouki, A. Ziadi, S. Younous, M.A. Samkaoui
Departamento de Anestesiología y Reanimación, Facultad de Medicina y Farmacia de Marrakech, Universidad Cadi Ayyad, Marrakech, Morocco
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (1)
Table 1. Laboratory parameters, results, and normal ranges.
Abstract

Recently, few reports have described a serious condition linked to SARS-CoV-2 that mimics Kawasaki disease called multisystem inflammatory syndrome, especially in children (MIS-C) and young adults. In this work, we report on a severe form of MIS in a young female adult previously infected by SARS-CoV-2. She was treated by plasmapheresis with albumin and steroids, however outcome was fatal. We discuss the pathogenesis of this rare and life threatening entity and suggest some therapeutic regimen. This syndrome should not be misdiagnosed with an infectious or a drug induced cutaneous rash in the current context of COVID-19 pandemic.

Keywords:
Adult
COVID-19
Kawasaki disease
Multisystem inflammatory syndrome
Resumen

Pocos informes han descrito recientemente una situación grave asociada a SARS-CoV-2 que remede la enfermedad de Kawasaki denominada síndrome inflamatorio multisistémico, especialmente en niños (MIS-C) y adultos jóvenes. En este trabajo, reportamos una forma grave de MIS en un adulto joven previamente infectado por SARS-CoV-2. La paciente fue tratada mediante plasmaféresis con albúmina y esteroides, pero sin embargo el resultado fue fatal. Tratamos aquí la patogenia de esta entidad rara y potencialmente mortal, y sugerimos algún régimen terapéutico. No debería confundirse este síndrome con una erupción cutánea infecciosa o causada por un fármaco en el contexto actual de la pandemia por COVID-19.

Palabras clave:
Adulto
COVID-19
Enfermedad de Kawasaki
Síndrome inflamatorio multisistémico

Article

These are the options to access the full texts of the publication Revista Española de Anestesiología y Reanimación (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Española de Anestesiología y Reanimación (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos